A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Clinical trial NCT00883779 · COMPLETED
Trial details
- NCT number
- NCT00883779
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2014-12-01
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.